Back

Cutting-free application of CRISPR-mediated endogenous gene activation in human induced pluripotent stem cell derived cardiomyocytes and engineered human myocardium

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Basic science e-posters Gene Therapy, Cell Therapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Eric Schoger

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

202 More presentations in this session

Presentation thumbnail
Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress
Doctor T. Yamamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes
Doctor C. Lo (Miaoli, TW)
Abstract Slides
Presentation thumbnail
Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense
Professor I. Andreadou (Athens, GR)
Abstract Slides
Presentation thumbnail
Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Melatonin receptor blockade slows ventricular conduction by IK1 downregulation
Doctor M. Gonotkov (Syktyvkar, RU)
Abstract Slides

Access the full session

Session thumbnail
Basic science e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Single-cell sequencing of the healthy and diseased heart reveals Ckap4 as a new modulator of fibroblasts activation.
21 April 2018
thumbnail
Congress Presentation
RNA therapies for cardiac gene editing
26 August 2023
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023
thumbnail
Congress Presentation
Towards advanced cardiac miRNA therapies through DNA-based nanostructures
29 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources